Ovarian cancer is the fifth most common type of cancer and second common cause of death among women in the world today. It is now recognized that cancer is actually a complex array of different diseases, with different genetics and different behaviors. Understanding the genetic alterations that are typical of cancer, there is a need to develop
a completely revolutionized research and a leading cause of gynecological disorder. As per statistics of Globocan 2008 and IARC, ovarian cancer is fifth most common cancer as well as fifth most common cause of cancer related mortality and morbidity in females.
Nearly 28,080 new cases and 19,558 deaths per year with ovarian cancer have been reported from India as one of the example of developing country. Moreover, every fifth death from ovarian cancer is from India, this is very alarming signal and need of hour is to mitigate this menace. (Basu Dev Banerjee, Reproductive System & Sexual Disorders)
Ovarian cancer remains the leading cause of death from all gynaecological tumors due to the lack of both symptoms at an early stage and a reliable clinical test. The majority (85-90%) of ovarian cancer is classified as epithelial histology and is the most aggressive
form of this cancer. The dismal fact is that 75% of patients are diagnosed when the tumor has spread or metastasized into the peritoneal wall or abdominal cavity. (Ying Dong, Transforming the Future of Treatment for Ovarian Cancer)
Last date updated on September, 2020